Amoebiasis is the second leading cause of death from parasitic disease worldwide. The
causative protozoan parasite, Entamoeba histolytica, is a potent pathogen. Secreting …

The detection of Entamoeba histolytica, the causative agent of amebiasis, is an important
goal of the clinical microbiology laboratory. To assess the scope of E. histolytica infection, it …

Clinical microbiology laboratories need to communicate results of antibacterial susceptibility
testing to prescribers. Sophisticated prescribers who are knowledgeable of the …

The genus Entamoeba contains many species, six of which (Entamoeba histolytica,
Entamoeba dispar, Entamoeba moshkovskii, Entamoeba polecki, Entamoeba coli, and …

▪ Abstract Entamoeba histolytica, as its name suggests, is an enteric parasite with a
remarkable ability to lyse host tissues. However, the interaction of the parasite with the host …

The epidemiology of amebiasis has dramatically changed since the separation of
Entamoeba histolytica and Entamoeba dispar species, and the worldwide prevalence of …

Entamoeba moshkovskii cysts are morphologically indistinguishable from those of the
disease-causing species E. histolytica and the nonpathogenic E. dispar. Although sporadic …

Study Design: Two genes exhibiting intrastrain variability were identified as potential targets
for strain differentiation: the acidic repeat protein (arp) gene, which contains a variable …

Entamoeba histolytica, the causative agent of human amebiasis, remains a significant cause
of morbidity and mortality in developing countries and is responsible for up to 100,000 …

Amebiasis is the third leading parasitic cause of death worldwide, and it is not known
whether immunity is acquired from a previous infection. An investigation was done to …